Madison El-Saadi Analyst PerformanceAnalyst at BTIG ResearchMadison El-Saadi is a stock analyst at BTIG Research in the healthcare sector, covering 12 publicly traded companies. Over the past year, Madison El-Saadi has issued 24 stock ratings, including buy and hold recommendations. While full access to Madison El-Saadi's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Madison El-Saadi's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings28 Last 1 YearsBuy Recommendations96.43% 27 Buy RatingsCompanies Covered12 Unique Companies Ratings Distribution28RatingsDistribution of strong buy, buy, hold, and sell ratings by Madison El-Saadi.RatingPercentageCount Strong Buy0.0%0 ratings Buy96.4%27 ratings Hold3.6%1 ratings Sell0.0%0 ratingsOut of 28 total stock ratings issued by Madison El-Saadi at BTIG Research, the majority (96.4%) have been Buy recommendations, followed by 3.6% Hold.Best & Worst CallsBest Call0000.0%CAPRJun 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%VNDANov 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ12 companiesMadison El-Saadi, an analyst at BTIG Research, currently covers 12 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare12 companies100.0%Madison El-Saadi of BTIG Research specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentagePHARMACEUTICALS5 companies41.7%BIOTECHNOLOGY5 companies41.7%HEALTHCARE EQUIPMENT & SUPPLIES2 companies16.7% Madison El-Saadi's Ratings History at BTIG Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsETONEton Pharmaceuticals11/10/2026Boost Price Target$66.65$81.00Buy$0.0000.00% ROIWVEWAVE Life Sciences11/9/2026Reiterated Rating$3.35$18.00Buy$0.0000.00% ROISTIMNeuronetics11/6/2026Boost Price Target$2.37$6.00Buy$0.0000.00% ROIANIKAnika Therapeutics9/18/2026Initiated Coverage$21.03$23.00Buy$0.0000.00% ROIOBIOOrchestra BioMed9/15/2026Boost Price Target$6.01$11.00Buy$0.0000.00% ROIOBIOOrchestra BioMed9/15/2026Boost Price Target$5.95$11.00Buy$0.0000.00% ROICAPRCapricor Therapeutics9/14/2026Upgrade$8.37$21.00Buy$0.0000.00% ROICAPRCapricor Therapeutics9/14/2026Upgrade$8.37$21.00Buy$0.0000.00% ROISTIMNeuronetics9/11/2026Initiated Coverage$3.01$5.00Buy$0.0000.00% ROIETONEton Pharmaceuticals8/14/2026Reiterated Rating$56.91$70.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. FENCAdherex Technologies8/12/2026Reiterated Rating$11.99$18.00Buy$0.0000.00% ROIVNDAVanda Pharmaceuticals8/10/2026Reiterated Rating$4.91$12.00Buy$0.0000.00% ROICMPSCompass Pathways8/6/2026Boost Price Target$13.73$22.00Buy$0.0000.00% ROIWVEWAVE Life Sciences7/31/2026Lower Price Target$5.61$22.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals7/30/2026Boost Price Target$86.87$123.00Buy$0.0000.00% ROICAPRCapricor Therapeutics7/27/2026Downgrade$6.45$10.00Neutral$0.0000.00% ROISPRBSpruce Biosciences7/13/2026Initiated Coverage$50.07$160.00Buy$0.0000.00% ROICMPSCompass Pathways4/24/2026Initiated Coverage$9.15$17.00Buy$0.0000.00% ROIETONEton Pharmaceuticals3/20/2026Boost Price Target$22.67$31.00Buy$0.0000.00% ROICAPRCapricor Therapeutics3/13/2026Boost Price Target$30.70$63.00Buy$0.0000.00% ROIARWRArrowhead Pharmaceuticals1/22/2026Boost Price Target$67.60$101.00Buy$0.0000.00% ROIVNDAVanda Pharmaceuticals12/31/2025Boost Price Target$7.03$14.00Buy$0.0000.00% ROICAPRCapricor Therapeutics12/15/2025Reiterated Rating$26.02$50.00Buy$0.0000.00% ROIWVEWAVE Life Sciences12/12/2025Boost Price Target$16.75$37.00Buy$0.0000.00% ROIVNDAVanda Pharmaceuticals11/5/2025Initiated Coverage$4.35$11.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics10/1/2025Initiated Coverage$121.45$179.00Buy$000.0000.00% ROICAPRCapricor Therapeutics6/26/2025Initiated Coverage$10.05$21.00Buy$00.0000.00% ROIETONEton Pharmaceuticals1/10/2025Initiated Coverage$12.01$21.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsRaymond James Financial Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
